NAVIDEA BIOPHARMACEUTICALS, INC. 4
4 · NAVIDEA BIOPHARMACEUTICALS, INC. · Filed Mar 11, 2014
Insider Transaction Report
Form 4
Cope Frederick O
Vice President
Transactions
- Sale
Common Stock
2014-03-10$1.96/sh−15,000$29,400→ 75,814 total
Holdings
- 8,637(indirect: By 401(k))
Common Stock
Footnotes (1)
- [F1]Sales were effected to generate funds required to cover tax obligations arising from expiring options or the vesting of shares of restricted stock. The transaction is matchable under Section 16(b) of the Securities Exchange Act with Dr. Cope's purchase of 3,500 shares of common stock at $1.43 per share on November 8, 2013. As a result, Dr. Cope will pay the company $1,855 representing the full amount of the profit realized in connection with the short-swing transaction.